Cardinal Health CAH Pharmaceutical and Specialty Solutions — Total Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cardinal Health in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cardinal Health's pharmaceutical and specialty solutions — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cardinal Health's pharmaceutical and specialty solutions — total assets?
- Cardinal Health (CAH) reported pharmaceutical and specialty solutions — total assets of $41.03B in Q1 2026.
- How has Cardinal Health's pharmaceutical and specialty solutions — total assets changed year-over-year?
- Cardinal Health's pharmaceutical and specialty solutions — total assets increased by 14.8% year-over-year, from $35.73B to $41.03B.
- What does pharmaceutical and specialty solutions — total assets mean?
- The total value of all assets, including inventory, accounts receivable, property, plant, equipment, and goodwill, specifically attributed to the Pharmaceutical and Specialty Solutions segment. This metric represents the capital base utilized by the segment to generate its revenue and earnings. It is used to assess the segment's asset intensity and return on invested capital.